Key facts
- This page summarizes John F. Crowley's Form 4 filing for AMICUS THERAPEUTICS, INC. (FOLD).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Jan 2024, 18:33.
John F. Crowley - 02 Jan 2024 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)
- Reporting relationship
- Executive Chairman, Director
- Issuer ticker
- FOLD
- Reported as of
- 02 Jan 2024
- Net transaction value
- -$1,466,882
- SEC form
- 4
- Accepted by SEC
- 04 Jan 2024, 18:33:06 UTC
- Prior SEC filing
- 19 Dec 2023
- Next SEC filing
- 05 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Formica, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John F. Crowley filed Form 4 for AMICUS THERAPEUTICS, INC. (FOLD) on 04 Jan 2024.
Change
- Previous filing in this sequence was filed on 19 Dec 2023.
- Current net transaction value: -$1,466,882.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
FOLD
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +144,628
- Change %
- +16%
- Price
- $0.000000
- Shares after
- 1,056,948
- Date
- 02 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
FOLD
transaction
Common Stock
Tax liability
- Transaction value
- $1,466,882
- Shares
- -108,417
- Change %
- -10%
- Price
- $13.53
- Shares after
- 948,531
- Date
- 03 Jan 2024
- Ownership
- Direct
FOLD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 64,895
- Date
- 02 Jan 2024
- Ownership
- By Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
FOLD
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +249,665
- Change %
- Price
- $0.000000
- Shares after
- 249,665
- Date
- 02 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 249,665
- Exercise price
- $14.24
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
Footnote F2
One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.
SEC remarks
The above grants were made pursuant to the employment contract between Mr. Crowley and Amicus, dated August 1, 2022.